Melissa P Wasserstein Md

Melissa Wasserstein, MD - Lysosomal Diseases for NBS (2013 SERN/SERGG Annual Conference)

SERGG Southeast Regional Genetics Group

Melissa Wasserstein: ScreenPlus

International Conference on Newborn Sequencing

Dr. Wasserstein Discusses 3 Rare Diseases

Dr. Wasserstein and Dr. Walkley speak to the Salla Treatment and Research Foundation

Salla Treatment And Research Foundation

Expanding OMB requirements

EveryLife Foundation for Rare Diseases

Salla Disease Workgroup (2022 GLIA Scientific Meeting)

Global Leukodystrophy Initiative

RUSP and the ScreenPlus Panel

The Limited Treatment Options for Rare Diseases

The Importance of Advocacy Groups for Rare Disease Patients

Eliminating the Diagnostic Odyssey with Newborn Screening

The Challenges of Diagnosing Rare Diseases

Niemann-Pick Disease

Challenges of Recruiting Patients for Rare Disease Clinical Trials

22q11.2 Deletion Syndrome (also known as 22q)

Genetic Disease Foundation at Mount Sinai

Mount Sinai Health System

Krabbe Disease

Assessing the Role of Emerging Therapies in the Management of Acid Sphingomyelinase Deficiency

INFO Session: STAR Think Tank & Family Camp

Salla Treatment And Research Foundation

Niemann-Pick Diseases Type A and B

Post-Salla Disease "Think Tank" Discussion Between Researchers and Families

Salla Treatment And Research Foundation